FILE PHOTO: View of Pfizer’s new respiratory syncytial virus (RSV)

FILE PHOTO: View of Pfizer’s new respiratory syncytial virus (RSV) vaccine Abrysvo during its manufacture in this undated handout picture. Pfizer/Handout via REUTERS THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY MANDATORY CREDIT/File Photo